GSK Plc (GLAXF)
26.75
+0.70
(+2.69%)
USD |
OTCM |
Apr 02, 16:00
GSK EPS Diluted (Quarterly) : 0.207 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.0831 |
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | -0.7979 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 966.83M |
| Revenue (Quarterly) | 11.46B |
| Total Expenses (Quarterly) | 10.62B |
| Enterprise Value | 125.60B |
| Gross Profit Margin (Quarterly) | 69.38% |
| Profit Margin (Quarterly) | 8.44% |
| Earnings Yield | 6.85% |
| Operating Earnings Yield | 8.86% |
| Normalized Earnings Yield | 7.392 |